Repros Therapeutics (RPRX)
2.09
-0.02 -0.95%
NASDAQ
Sep 30, 20:00
Delayed 2m
USD
View All Key Stats
RPRX Key Stats
| Income Statement | |
| Revenue (TTM) | 0.041M |
| Revenue (Quarterly YoY Growth) | Upgrade |
| EPS Diluted (TTM) | -0.91 |
| EPS Diluted (Quarterly YoY Growth) | Upgrade |
| Net Income (TTM) | -22.00M |
| Profitability | |
| Gross Profit Margin (Quarterly) | -- |
| Profit Margin (Quarterly) | -28.53K% |
| Dividend | |
| Dividend Yield (Forward) | Upgrade |
| Dividend Yield (TTM) | 0.00 |
| Price and Valuation | |
| Market Cap | 50.83M |
| 52 Week High (Daily) | Upgrade |
| 52 Week Low (Daily) | Upgrade |
| PS Ratio (TTM) | 1239.65 |
| PE Ratio (TTM) | -- |
| Price to Book Value | 4.850 |
| Other | |
| Beta | Upgrade |
| Debt to Equity Ratio (Quarterly) | -- |
| Free Cash Flow (Quarterly) | -3.536M |
| Return on Equity (TTM) | -113.3% |
View All RPRX News
RPRX News
-
WireHeadlineTime (ET)
-
Yahoo09/27 13:03
-
MT Newswires09/26 11:35
-
Yahoo09/26 09:16
-
Globe Newswire09/26 09:15
-
Yahoo09/13 09:50
-
Yahoo09/12 16:08
-
MT Newswires09/12 11:55
-
Globe Newswire09/12 11:45
-
MT Newswires09/08 16:29
-
MT Newswires09/08 16:12
View All Events
RPRX Events
| Date | Type | Description |
|---|---|---|
| 08/09/2016 14:30 CDT | Earnings | Repros Therapeutics Inc Second Quarter Earnings Results in 2016 |
RPRX Fundamentals
Income Statement View Statement
Cash Flow Statement View Statement
RPRX Ratings
- Y-Rating Upgrade
- Value Score Upgrade
- Fundamental Score Upgrade
- Valuation (Hist. Mult.) Upgrade
- Y-Rating Report Download
Advertisement
One Page Reports
- One Page Report Download
Edit
Profile
- URL: http://www.reprosrx.com
- Investor Relations URL: http://ir.reprosrx.com/index.cfm
- HQ State/Province: Texas
- Sector: Healthcare
- Industry: Biotechnology
- Next Earnings Release: N/A
- Last Earnings Release: August 09, 2016
- Next Ex-Dividend Date: N/A
- Last Ex-Dividend Date: N/A
- Description: Repros Therapeutics Inc is a development stage biopharmaceutical company. The Company is engaged in the development of new drugs to treat hormonal and reproductive system disorders.
RPRX Comparables
EditRPRX Excel Add-In Codes
- Name: =YCI("RPRX","name")
- Description: =YCI("RPRX","description")
- Sector: =YCI("RPRX","sector")
- Industry: =YCI("RPRX","industry")
- Est. Current Fiscal Year End: =YCI("RPRX","fye")
To find the codes for any of our financial metrics, see our Complete Reference of Metric Codes.
Access our powerful Excel Add-in with a YCharts Professional Membership. Learn More.
Other RPRX Resources
- 13F Filings Whale Wisdom
- Call Transcripts Seeking Alpha
- Insider Trading Morningstar
- Institutional Ownership Nasdaq
- SEC Filings SEC
- RPRX Tweets Stocktwits
Advertisement